Canada mulls global vaccine contribution as Trump turns back on alliance
OTTAWA — Canada is still considering a contribution to the international vaccine coalition known as COVAX, which aims to equitably distribute a COVID-19 vaccine to poorer countries that can’t afford one.
The decision stands in contrast to Tuesday’s decision by the Trump administration in the United States to opt-out of the alliance of more than 150 countries because the program is linked to the World Health Organization.
President Donald Trump ended U.S. funding to the WHO in July because he says it is being unduly influenced by China and needs to be reformed.
A spokesman for Karina Gould, Canada’s International Development Minister, says the Trudeau government is working on the details of a spending commitment to what’s called the “COVAX Facility,” which is designed to ensure developing countries have fair access to a COVID-19 cure.
COVAX also allows investing countries to be given early access for up to 20 per cent of their populations.
The initiative is aimed at circumventing so-called vaccine nationalism — the scramble by individual countries to secure vaccines for their own populations, often by pre-buying doses directly from pharmaceutical companies.
- Feds pledge $440 million to join international vaccine program
- Canada urged to avoid ‘vaccine nationalism’ in race for COVID-19 cure
- Canadians not worried other countries will get COVID-19 vaccine first: poll
- PM wants answers from China, other countries on early days of COVID-19
- Canada boosts foreign aid by $485 million with new funds for global COVID-19 effort
- CAUGHT ON VIDEO: Major road closed in aftermath of fatal crash in Mississauga
- This Mississauga neighbourhood has one of the highest COVID-19 percent positivity rates in Ontario
- ‘You don’t want to fall into that three per cent category’: Ontario ICU doctor on battling COVID-19
- Major road closed due to serious crash in Mississauga
- Environment Canada issues snowfall warning for Mississauga